Exhibit 107
Calculation of Filing Fee Table
Form S-1
(Form Type)
Bicara Therapeutics Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price per Unit | Proposed Aggregate Offering Price(1)(2) | Fee Rate | Amount of Registration Fee | |||||||||
| NEWLY REGISTERED SECURITIES | ||||||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | 457(a) | 3,213,236(1) | $18.00(1) | $57,838,248.00 | 0.00014760 | $8,536.93 | ||||||||
Fees Previously Paid | — | — | — | — | — | — | — | |||||||||
| CARRY FORWARD SECURITIES | ||||||||||||||||
Carry Forward Securities | — | — | — | — | — | |||||||||||
| Total Offering Amounts | $57,838,248.00 | $8,536.93 | ||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $8,536.93(3) | |||||||||||||||
| (1) | Represents only the additional number of shares being registered and includes 419,118 shares of common stock that the underwriters have the option to purchase. Does not include the securities that the Registrant previously registered on the Registration Statement on Form S-1 (File No. 333-281722), as amended (the “Prior Registration Statement”). |
| (2) | Estimated solely for the purpose of computing the registration fee in accordance with Rule 457(a) under the Securities Act of 1933, as amended (the “Securities Act”). |
| (3) | The registration fee is calculated in accordance with Rule 457(a) under the Securities Act based on the proposed maximum aggregate offering price. The registrant previously registered securities on the Prior Registration Statement having a proposed maximum aggregate offering price of $304,411,752, which was declared effective by the Securities and Exchange Commission on September 12, 2024. In accordance with Rule 462(b) under the Securities Act, an additional amount of securities having a proposed maximum aggregate offering price of $57,838,248.00 is hereby registered, which includes shares issuable upon the exercise of the underwriters’ option to purchase additional shares. |